GE HealthCare Technologies Inc. $GEHC Shares Acquired by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 146.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,372 shares of the company’s stock after buying an additional 13,895 shares during the quarter. Los Angeles Capital Management LLC’s holdings in GE HealthCare Technologies were worth $1,753,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in GEHC. Allstate Corp increased its holdings in GE HealthCare Technologies by 100.3% in the 4th quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after purchasing an additional 16,365 shares during the last quarter. Temasek Holdings Private Ltd acquired a new position in GE HealthCare Technologies during the third quarter worth $99,922,000. Envestnet Asset Management Inc. boosted its position in shares of GE HealthCare Technologies by 15.8% during the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after buying an additional 46,231 shares during the period. Sound Shore Management Inc CT boosted its position in shares of GE HealthCare Technologies by 14.6% during the third quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock worth $73,655,000 after buying an additional 125,062 shares during the period. Finally, Waverton Investment Management Ltd grew its stake in shares of GE HealthCare Technologies by 2.8% in the third quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock valued at $81,582,000 after buying an additional 29,897 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on GEHC shares. Citigroup cut their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Barclays dropped their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research report on Thursday, April 30th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Piper Sandler reduced their price target on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Finally, Mizuho lowered their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

Insider Activity

In other news, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 1st. The shares were purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. The trade was a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Watkin Phoebe L. Yang purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average price of $63.01 per share, with a total value of $63,010.00. Following the purchase, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Trading Down 3.4%

GEHC opened at $63.76 on Thursday. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The stock has a market capitalization of $29.00 billion, a price-to-earnings ratio of 15.25, a PEG ratio of 1.49 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The business has a fifty day moving average price of $66.59 and a 200 day moving average price of $75.36.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.